Blog

Software companies make fantastic investments due to their favorable margin profile. They provide software, which costs little to make over the long run compared physical goods like cars. Superior

Cryptocurrency has had quite the year, with many cryptocurrencies experiencing explosive growth. Bitcoin (CRYPTO: BTC) remains the most popular, with a market cap of nearly $900 billion.

However

Over the past few years, several technology-focused insurance disruptors have come on to the public markets, but Lemonade (NYSE: LMND) is emerging as a winner in the space. In this Fool Live video

The cryptocurrency market has taken a downturn recently. Some investors fear that this could be the start of a correction to rival the enormous plunge of 2017. Back then, leading cryptocurrency

If you follow the stock market regularly, you've almost certainly noticed that volatility has picked up lately. From the omicron variant uncertainty to fears about inflation, investors are more on

Growth stocks have fallen out of favor over the past month; many have dropped noticeably off highs, and investors are trying to figure out when there might be a rebound. But when things seem dark

Electric truck company Rivian Automotive (NASDAQ: RIVN) has been receiving a lot of love on Wall Street of late as analysts seem convinced about the company's ability to sell a truckload of vehicles

There is no better vehicle for creating wealth than investing in stocks and no better market for it than U.S. exchanges. The relative transparency, regulatory oversight, high liquidity, and the U.S

Cryptocurrencies have taken over where last year's coronavirus vaccine stocks left off. And their gains have been even bigger. For example, vaccine stock Novavax soared 2,700% last year. This year

The end of the year is the perfect opportunity to double-check your portfolio and make sure all your investments deserve to be there. It's also a smart time to add new investments and start the new

Ethereum (CRYPTO: ETH) has been a success story no matter how you look at it. Its native Ether token now ranks as the second-biggest cryptocurrency based on market cap, behind only Bitcoin (CRYPTO:

In a little over two weeks, the curtain will close on what should go down as another winning year for the stock market. Through this past weekend, the broad-based S&P 500 had gained 25%, which is

Soaring inflation and fear of rising interest rates aren't doing any favors for the stock market lately. For high-growth stocks tied to businesses that rely on cheap and plentiful capital to

No asset class has been hotter since the coronavirus pandemic bottom in March 2020 than cryptocurrencies. Over the past 21 months, the aggregate value of digital currencies has vaulted higher by

By the time you sign up for Social Security, you've spent decades paying into the program. It's only natural that you'd want to get the most out of it. You may have heard that delaying benefits

Elon Musk has long dreamed of taking people to Mars and leaving them there (he says he'll build a habitat) and has hinted on and off about these plans for years. A recent Tweet from Musk, in

For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.

Think Elon

For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.

The world's

For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.

Shoppers are

Shares of Alzamend Neuro (NASDAQ: ALZN) surged 28% on Tuesday, as investors bought in ahead of the biotech's upcoming clinical data release for its experimental Alzheimer's treatment. 

Alzamend is

On a gloomy day for the stock market, healthcare aesthetics specialist Soliton (NASDAQ: SOLY) was a luminous bright spot on Tuesday. The company's shares rocketed almost 12% higher, on news that its

Global Blood Therapeutics (NASDAQ: GBT) shares took a big dive on Tuesday, sliding to close more than 14% lower. Investors weren't happy that the company is launching a big new round of financing.

Thanks to Realty Income's (NYSE: O) purchase of VEREIT, I now own both this real estate investment trust (REIT) and its "rival" W.P. Carey (NYSE: WPC). I'm happy about that, but what if you only

Tuesday continued a tough week on Wall Street, with indexes moving lower again. A high reading on producer prices signaled that inflation could be a persistent problem, and now, market participants

Canadian cannabis company Hexo (NASDAQ: HEXO) reported its fiscal first-quarter 2022 results today, and investors were disappointed. In addition to a net loss of more than $90 million, the company